OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 16 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $47,000 | -88.3% | 100,000 | -93.2% | 0.00% | – |
| Q4 2016 | $402,000 | +1335.7% | 1,460,000 | +1360.0% | 0.00% | – |
| Q3 2016 | $28,000 | -96.6% | 100,000 | -91.5% | 0.00% | – |
| Q3 2015 | $817,000 | +11571.4% | 1,176,000 | +16700.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 9,826,000 | $2,358,000 | 1.48% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,000,000 | $3,300,000 | 1.00% |
| BVF INC/IL | 10,000,000 | $2,650,000 | 0.50% |
| Partner Investment Management, L.P. | 403,000 | $111,000 | 0.16% |
| PFM Health Sciences, LP | 16,072,000 | $4,446,000 | 0.13% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 21,414,000 | $5,934,000,000 | 0.09% |
| Verition Fund Management LLC | 2,066,000 | $547,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,653,000 | $2,943,000 | 0.05% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,000,000 | $1,623,000 | 0.02% |
| Orbimed Advisors | 5,210,000 | $1,441,000 | 0.02% |